Richter Jumps as FDA Approves Expanded Use of Blockbuster Drug

(Bloomberg) -- Gedeon Richter Nyrt., eastern Europe’s largest drugmaker, rallied the most since July after the U.S. approved the expanded use of its blockbuster anti-psychotic Vraylar.